Status:

RECRUITING

A Game-based Neurodevelopmental Assessment for Young Children

Lead Sponsor:

Brightlobe Limited

Conditions:

Neurodevelopmental Disorders

Autism Spectrum Disorder

Eligibility:

All Genders

3-8 years

Brief Summary

The aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old. The study's main aims are: (1) to determine whether the nov...

Eligibility Criteria

Inclusion Criteria:

  • 3 to 8 year old 'typically' developing children with no known neurodevelopmental disorder.

OR

  • 3 to 8 year old children with a diagnosed neurodevelopmental disorder, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder.

All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment.

Exclusion Criteria:

  • Children with medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.

Key Trial Info

Start Date :

January 30 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

590 Patients enrolled

Trial Details

Trial ID

NCT05780853

Start Date

January 30 2023

End Date

June 30 2026

Last Update

July 25 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brightlobe Limited

London, United Kingdom